Trademark Overview
On Monday, December 1, 2025, a trademark application was filed for REZOLV with the United States Patent and Trademark Office. The USPTO has given the REZOLV trademark a serial number of 99523763. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, April 3, 2026. This trademark is owned by Harbinger Health, Inc.. The REZOLV trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
Medical research services for measuring positive predictive value for cancer screening and for high resolution cancer screening and risk stratification;Software featuring machine learning and AI for analyzing positive predictive value for cancer;Software featuring machine learning and AI for high resolution cancer screening and risk stratification: Medical diagnostic apparatus for detecting cancer;cancer screening and detection tools, namely, medical diagnostic apparatus for testing cancer cells and potential cancer cells;blood testing apparatus for use in the diagnosis of cancer;liquid biopsy testing apparatus
